Indacaterol/Mometasone (TWISTHALER)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Indacaterol/Mometasone (TWISTHALER), covering 2013-03-21 to 2013-03-21. Get the full timeline:
Most recent: Clinical Trial Update: Investigation of the 24 Hour Forced Expiratory Flow in 1 Second (FEV1) Profile of a Single Dose of Indacaterol/Mometasone Delivered Via the TWISTHALER® Device in Adult Patients With Persistent Asthma [Phase 2]